Measurement of antibody-membrane interactions by surface plasmon resonance

Alexander Klimka1, Mehmet K Tur, Michael Huhn

  • 1Department of Pharmaceutical Product Development, Fraunhofer IME, Worringerweg 1, 52074 Aachen, Germany.

Insights

This study presents a novel surface plasmon resonance method for direct antibody-cell membrane interaction analysis. This technique overcomes limitations of existing immunoassays, enabling precise kinetic binding data for antibody discovery.

Area of Science:

  • Biochemistry
  • Immunology
  • Biotechnology

Background:

  • Evaluating antibody binding to cell surface antigens is crucial for cancer diagnostics and therapeutics.
  • Traditional immunoassays like ELISA have limitations in providing direct kinetic binding data and maintaining antigen conformation.

Purpose of the Study:

  • To develop and validate a new method for visualizing direct antibody-cell membrane interactions.
  • To overcome limitations of current immunoassays for analyzing antibody binding to functional tumor antigens.

Main Methods:

  • Utilized surface plasmon resonance (SPR) with a Biacore 3000 instrument.
  • Developed a method for coating cell membrane preparations onto a carboxymethyl dextran hydrogel chip.
  • Employed on-line signal subtraction using antigen-negative cell membrane vesicles for accurate measurements.
  • Analyzed interactions of anti-CD30 and anti-carcinoembryonic antigen (CEA) antibodies with specific cell membrane vesicles.

Main Results:

  • Successfully established conditions for coating cell membrane preparations onto SPR chips.
  • Demonstrated proof of concept by analyzing antibody-antigen interactions with high specificity.
  • Obtained direct kinetic binding information for antibody-cell membrane interactions.

Conclusions:

  • The developed SPR method enables direct visualization and kinetic analysis of antibody-cell membrane interactions.
  • This technique offers a significant advancement over existing methods for evaluating antibodies targeting cell surface antigens.
  • The method is applicable for analyzing antibodies against various tumor antigens like CD30 and CEA.

Related Concept Videos